ISM Immune System Management is a biotechnology company based in Canada that specializes in reversing immunosenescence and mitigating the risks of chronic disease. With over 20 years of experience, ISM has focused on blood plasma amino acid analysis and the development of customized therapeutics to rebalance the immune system. The company has amassed an extensive database, having analyzed the blood plasma amino acid profiles of thousands of clients, resulting in millions of data points. This has enabled ISM to create the most comprehensive mapping of the human aminome. As of now, there is no public information available about the last investment or the investors involved with ISM Immune System Management. As a biotechnology startup with a unique approach to immune system management, ISM has the potential to make a significant impact in the field of personalized medicine and immune system rejuvenation.
There is no investment information
No recent news or press coverage available for ISM Immune System Management.